OpenLegislation

Regulation 26 Change of ownership applications

United Kingdom

(1)

Section 129(2A) of the 2006 Act M1 (regulations as to pharmaceutical services) does not apply to an application from a person who is not included in a pharmaceutical list for inclusion in the list, or from a person included in a pharmaceutical list for inclusion in that list also in respect of other premises than those already listed in relation to that person, if—

(a)

the applicant (X) is undertaking to provide pharmaceutical services at F1or from premises—

(i)

that are already listed chemist premises, and

(ii)

at F2or from which another person (Y) is providing pharmaceutical services;

(b)

X is proposing to carry on at F3or from the listed chemist premises, in place of Y, the business in the course of which Y is providing pharmaceutical services at F4or from those premises;

(c)

X is undertaking to provide the same pharmaceutical services as those that Y is providing; and

(d)

the provision of pharmaceutical services at F5or from the premises will not be interrupted (except for such period as F6NHS England may for good cause allow).

(2)

Section 129(2A) of the 2006 Act does not apply to an application from a person who is not included in a pharmaceutical list for the area of a HWB (HWB1) for inclusion in that list, or from a person included in a pharmaceutical list for inclusion in that list also in respect of other premises than those already listed in relation to that person, if—

(a)

the applicant (X) is undertaking to provide the pharmaceutical services that another person (Y)—

(i)

is providing at F7or from listed chemist premises (“Y's premises”), whether in the area of HWB1 or a neighbouring HWB, or

(ii)

has provided at F8or from Y's premises but Y is no longer able to provide pharmaceutical services at F9or from those premises for reasons that NHS England accepts are good cause;

(b)

X is proposing to carry on, in place of Y, the business in the course of which Y is providing, or has provided, pharmaceutical services at F10or from Y's premises;

(c)

X is undertaking to provide the same pharmaceutical services as Y is providing or has provided at F11or from Y's premises, but at F12or from different premises (“X's premises”);

(d)

F13had Y applied to move to X's premises, that application would have been granted under regulation 24; and

(e)

F14in a case where pharmaceutical services—

(i)

are being provided at F15or from Y's premises, the provision of pharmaceutical services will not be interrupted (except for such period as NHS England may for good cause allow) by the move of the business from Y's premises to X's premises, or

(ii)

are not being provided at F16or from Y's premises, the provision of pharmaceutical services will commence at F17or from X's premises within the period that NHS England considers is an acceptable period for the interruption of the provision of pharmaceutical services by the business that X is taking over.

F18(3)

An application pursuant to paragraph (1) must be refused if it relates to distance selling premises, unless the application, if made pursuant to regulation 25(1), would not be refused pursuant to regulation 25(2).

(4)

An application pursuant to paragraph (2) must be refused if the existing pharmacy premises from which the applicant is seeking to relocate are distance selling premises, unless the premises to which the applicant is seeking to relocate are also distance selling premises (and this is in addition to the requirement that arises by virtue of paragraph (2)(d) that the application, if made pursuant to regulation 25(1), would not be refused pursuant to regulation 25(2)).

Annotations

Textual amendments

F1

Words in reg. 26(1)(a) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(2)(a)(i)

F2

Words in reg. 26(1)(a)(ii) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(2)(a)(ii)

F3

Words in reg. 26(1)(b) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(2)(b)(i)

F4

Words in reg. 26(1)(b) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(2)(b)(ii)

F5

Words in reg. 26(1)(d) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(2)(c)

F6

Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1

F7

Words in reg. 26(2)(a)(i) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(a)(i)

F8

Words in reg. 26(2)(a)(ii) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(a)(ii)(aa)

F9

Words in reg. 26(2)(a)(ii) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(a)(ii)(bb)

F10

Words in reg. 26(2)(b) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(b)

F11

Words in reg. 26(2)(c) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(c)(i)

F12

Words in reg. 26(2)(c) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(c)(ii)

F13

Words in reg. 26(2)(d) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 9(a)(i)

F14

Words in reg. 26(2)(e) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 9(a)(ii)

F15

Words in reg. 26(2)(e)(i) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(d)(i)

F16

Words in reg. 26(2)(e)(ii) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(d)(ii)(aa)

F17

Words in reg. 26(2)(e)(ii) inserted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 20(3)(d)(ii)(bb)

F18

Reg. 26(3)(4) inserted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 9(b)

Marginal citations

M1

Section 129(2A) was inserted by the Health Act 2009 (c. 21), section 26(3), and has been amended by the Health and Social Care Act 2012 (c. 7), section 207(4), and Schedule 4, paragraph 66(5).